Search Results: ives/ (139)

A new study found that people who are more likely to develop schizophrenia are more likely to try cannabis. It also found  new evidence that cannabis use can cause schizophrenia.

The number of pregnant women who use cannabis is  up more than 60% since 2002. While knowledge of how cannabis affects fetuses is limited, Dr. Nora Volkow, head of the National Institute on Drug Abuse, called it “cause for concern.”

The Duluth News Tribune looks examines the case for, and against,  treating PTSD with MED.

More experts say cannabis  should be prescribed before opiates, VICE reports.

Ohio doctors say they’re  reluctant to recommend MED.

An article from “The American Tribune” on an overdose from injecting cannabis  turned out to be fake news.

Connecticut has approved its first MED study,  to compare pain relief with an opiate in patients with fractured ribs. A Connecticut hospice will use cannabis to  reduce its dependence on opioids.

President Obama  granted clemency to 231 individuals. His total of more than 1,300 sentence commutations totals more than his 11 predecessors combined. Here’s the story of one of them,  Paul Free, who was serving a life sentence and is now eligible for parole in 2020.

Obama also granted  78 “pre-Christmas” pardons.

Vox examines how Obama has  reshaped the war on drugs, and how that legacy is will be jeopardized under President Trump. For one thing, Obama tended not to use the term “War on Drugs.”

A court ruled that Arizona MED users  can’t be convicted of DUI without evidence of impairment.

A Colorado man who drove impaired and  killed a motorcyclist was sentenced to 10 months in jail and two years probation.

A day after they opened, six unlicensed Cannabis Culture dispensaries were  raided and closed in Montreal. The 10 arrests included owner and “prince of pot” Marc Emery.

Spotted in D.C.: “ This is your brain on Jeff Sessions.

In Milton, Mass., a dispensary seeks to open in the historic “ Swift Hat Shop” building.

It doesn’t really change anything for now.

Here’s your daily dose of pot news from the newsletter WeedWeek.

The DEA confirmed that marijuana extracts containing CBD are illegal. The agency explained that the notice, published in the Federal Register, does not change its enforcement priorities.

Cannabis attorney Bob Hoban responded, “The sky is not falling; however, this is a very concerning move by the DEA…What it purports to do is give the DEA control of all cannabinoids as a controlled substance.”

More than 30% of cannabis businesses are very concerned about Trump’s presidency, according to a Marijuana Business Daily Poll. In particular, they’re worried about the U.S. attorney general nomination of prohibitionist Alabama Senator Jeff Sessions (R).

In Slate, I wrote that the industry is cowardly, hypocritical and stupid for not fighting the Sessions nomination. Legalization activist and journalist Tom Angell tweeted that I’m “ WAY off base” and then got into an interesting Twitter exchange with Bill Piper of Drug Policy Alliance, which is opposing the nomination.

The U.S. Senate extended the Rohrabacher-Farr amendment, which prohibits the federal government from interrupting state MED programs, until April 28. Rep. Dana Rohrabacher (R- Calif.) said he’s confident that it will be extended again. He also wants it to be expanded to include state REC programs.

Rohrabacher and Rep. Earl Blumenauer (D-Ore.) are forming a “ cannabis caucus” in Congress. Congress also announced that it will perform a comprehensive review of the war on drugs in search of alternative policies in the Caribbean and Latin America.

Colombian President Juan Manuel Santos, called for changes in U.S. drug policy, as he accepted the Nobel Peace Prize.

Mexico’s Senate passed a MED bill, amid a new wave of drug violence.

Maine’s REC recount has been suspended until the new year. With 30% of the votes counted, yes remains ahead. After Montana’s MED vote, state laws need to be rewritten.

Israel’s Teva Pharmaceuticals will start to distribute a medical cannabis inhaler developed by Syqe, an Israeli start-up that raised money from tobacco giant Philip Morris. The inhaler may also be tested with opiates.

An editorial in The Scientist says its unacceptable that the World Health Organization has not developed positions on legalization.

Toronto’s Hospital for Sick Children will begin a clinical trial of cannabis extracts containing CBD and THC for children with severe epilepsy.

A new study from Steep Hill Labs found that 83 percent of California weed wouldn’t pass Oregon’s testing standards. An industry report says Oregon’s strict regulations are crushing the state industry. Willamette Week reports that business conditions are pushing some entrepreneurs back to the underground market.

Rehab provider Spectrum Health Systems said a doctor was not to blame for revealing to a patient’s employer that she uses MED.

A survey of cannabis researchers finds out what they want from the government in order to pursue their work.

A Reason investigation finds that conservative authorities in Idaho “conspired to restrict a promising cannabis-derived seizure treatment.”

The National Fire Protection Association is developing fire safety standards for cannabis businesses.

The FDA will allow a late stage clinical trial for ecstasy as a treatment for PTSD.

Minnessota approved PTSD as a MED qualifying condition. New York approved chronic pain.

Canada’s legalization push is getting complicated. The much-anticipated task force report on legalizationhas been delayed. Meanwhile activists wonder why shops are getting raided if the government plans to legalize. For more see here.

Bill Blair a Canadian government official overseeing the issue appeared at a “ cash-for-access” fundraiser with cannabiz leaders that may have violated Liberal Party ethics guidelines. Blair defended recent raidssaying, “The only system for control is the existing legal regime. And we’re a society of laws,” he says.

Possibly the largest legal pot company in the world.

Here’s your daily dose of pot news from the newsletter WeedWeek.

Canada’s Canopy Growth Corp. will acquire Mettrum Health Corp. for C$430M, creating a dominant Canadian player.

Vice examines 280E, the tax code provision used to tax marijuana businesses more than other businesses.

Warehouse rents are skyrocketing in legal states. But the New York Stock Exchange IPO of cannabis real estate trust Innovative Industrial Properties went nowhere, following the Sessions nomination.

The BBC calls Albania, a small, poor country in southeast Europe, the continent’s “ outdoor cannabis capital.

The industry could create an opportunity for clean energy technologies like “ renewable microgrids.

LAWeekly asks if small cannabis businesses can survive legalization.

Accounting Today says, “ The Cannabis Industry Needs Accountants.

Pot was a hot topic at the 2016 Wine Industry Expo. For more see here.

Financial firm Cowen said legalization is bad for beer sales. MarketWatch disagrees.

Dispensaries offered discounts for “ Green Friday.” (The shopping day after Thanksgiving.)

The BBC profiles John Stewart, an executive who was CEO of Purdue Pharma, which sells the opioid Oxycontin and now leads a MED company in Canada.

There’s an incubator that aims to turn formerly-incarcerated drug dealers into legal entrepreneurs.

Century Bank in Massachusetts openly works with pot businesses.

A new site called The Cannifornian will cover legalization in the state.  Parent company Digital First Media also owns The Denver Post and its site The Cannabist.

RAND Corporation scholar Beau Kilmer editorializes in favor of the state legalization experiments.

Denver’s social use measure may face legal challenges. Juneau, Ak.’s first dispensary opened and sold out in three hours.

Maryland’s pot regulator has hired a diversity consultant, after it failed to award any of its initial 30 licenses to African-Americans. It has also given preliminary approval for 102 MED dispensary licenses. The names will be made public this week.

Florida’s MED community has few friends in Tallahassee. The new law will also undermine the state’s largely disregarded bong ban.

The Cannabist meets Rilie Ray Morgan, the 66-year old man who championed MED in North Dakota.

Colorado Gov. John Hickenlooper (D) is launching a new effort to use pot taxes to build apartments for the chronically homeless.

Massachusetts may delay implementing aspects of its REC law. Maine will recount its REC vote. MED legalization is on the table in Ireland and South Africa.

British politician Nick Clegg called for legalization. Vice sketches out what a legal U.K. market for recreational drugs could look like.

A little known aspect of busts.
Here’s your weekly dose of cannabis news from the newsletter WeedWeek.
An investigation in Reason finds “ widespread, unchecked violence against pets during drug raids.” Two Detroit officers it found have killed more than 100 dogs each.

The owner of Med-West, a San Diego extraction company that was raided by local authorities in January is seeking a return of his frozen assets. $324,000 cash was seized during the raid. No criminal charges have been filed.

Police departments are becoming more tolerant of applicants’ past pot smoking.

Las Vegas police said they would still pursue possession arrests, though the district attorney said they wouldn’t be prosecuted.

With Trump’s election, federal inmates incarcerated for non-violent drug offenses fear their window to win clemency is closing. “Some of these people are bad dudes,”  Trump said at an August rally “These are people out walking the streets. Sleep tight, folks.”

CBS tells the story of Harry Anslinger, a leading figure in passing the Marijuana Tax Act of 1937, which made it illegal.

The New Yorker sent Adrian Chen to the Philippines, where President Rodrigo Duterte is waging a brutal drug war. The article is subtly titled “ When a Populist Demagogue Takes Over.

In California, police are concerned about home grows.

Time Magazine calls hmbldt vape pens one of the 25 best inventions of 2016.
Ozy discovers “ happy pizza” in Cambodia. A Barcelona cannabis club was closed by authorities. There’s a cannabis/comic book convention today in Colorado Springs.

Vice learns how to make “ the most potent weed oil.”

The Washington Post recommends four books to understand the new weed reality. They include Marijuana: A Short History, by John Hudak, Jesse Ventura’s Marijuana Manifesto, Sacred Bliss: A Spiritual History of Cannabis by Mark S. Ferrara and Cooking with Cannabis by Laurie Goldrich.

The New Yorker published a pot-industry cartoon. It isn’t especially funny.

It follows an infamous raid..

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek. Download WeedWeek’s free 2016 election guide here.

Santa Ana, Calif. paid $100,000 to a the dispensary raided by police in 2015, and agreed to drop misdemeanor charges against employees, in exchange for them agreeing not to sue. Three officers face charges after surveillance footage recorded them mocking an amputee and playing darts during the raid. They argued that they shouldn’t be charged since they believed they had disabled all of the dispensary’s video cameras.

More stringently, in other words.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek. Download WeedWeek’s free 2016 election guide here.

Researchers at UCSF argue that the cannabis industry should be regulated more like tobacco than alcohol, for public health reasons. Sales should be “subject to a robust demand reduction program modeled on successful evidence-based tobacco control programs,” they write.

The new company will be a major player in seeds and pharmaceuticals, two cannabis sweet spots.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek. Download WeedWeek’s free 2016 election guide here.

In one of the largest mergers ever, the German chemical and pharamaceutical giant Bayer will buy seed company Monsanto for $66 billion. Mainstream reports did not bring it up, but both companies have long been seen as interested in the plant. (Bayer has a partnership with GW Pharmaceuticals.) In July, the far-left site Counterpunch published a piece called “ Monsanto, Bayer and the Push for Corporate Cannabis.”

Cannabis Reports CEO David Drake publicly shamed Leafly and Weedmaps for poor cybersecurity. Social network MassRoots and data firm Headset announced a strategic partnership.

At an L.A. conference, Viridian Capital Advisors president Scott Greiper said legalization will bring about the next industrial revolution.

Canna Law Blog discusses what makes for a weak brand mark? New cannabis business lawyer Daniel Shortt explains why he’s chosen the specialty.

 

Business school student Cameron Lehman writes about opening a dispensary with his plastic surgeon mom. U.C. Berkeley’s Haas business school is starting a speaker and case study series on the green rush.

Medical testing company Quest Diagnostics says the number of Americans testing positive for illegal drugs reached a decade high of 4%. Among “safety-sensitive” workers it was 1.8 %, a slight increase.

A new study found that states with legal, accessible MED saw decreases in opioid use in adults 21-40.

Reason asks “ What will control freaks ban next?” The answer appears to be the southeast Asian plant Kratom, which the DEA is adding to the list of schedule I drugs. Wired calls Kratom a promising treatmentfor opiate addition.

Dana-Farber Cancer Institute blogged on whether MED benefits cancer patients.

Food Safety News picked up a Leafly story about how to know if weed is past its sell-by date.

It currently sells a powerful opiate.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek

The Intercept reports that Insys Therapeutics, the company that donated $500,000 to oppose REC in Arizona, is about to release a synthetic THC spray to relieve side effects associated with chemotherapy that would compete directly with MED. It’s been more widely noted that Insys’ only current product is an opioid spray. Insys noted in a 2007 SEC filing that legalization is a threat to its business.

Forbes surveys a list of cannabis-involved pharmaceutical companies that are takeover targets. Insys is among them.

1 2 3 14